Glial Cell Line Derived Neurotrophic Factor Market By Type ( TW-002, AMT-090, GSK-812, LAUR-301 ), By Application ( Brain Ischemia, Retinal Degeneration, Parkinson's Disease, Amyotrophic Lateral Sclerosis ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 168

 ERC 3753

 Formats*:  

Glial Cell Line Derived Neurotrophic Factor Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Glial cell-derived neurotrophic factor (GDNF) is a small protein that facilitates the survival of various neurons. It is found to be effective in preventing the apoptosis of motor neurons that is induced by axotomy. The advent of glial cell-derived neurotrophic factor was based on its capability to promote the survival of dopaminergic neurons. However, advancements in technology have linked the importance of GDNF in the treatment of Parkinson’s disease, along with stroke and motoneuron injuries, owing to its ability to regenerate brain cells. According to the Parkinson Association of the Carolinas, every year approximately 60,000 people in America are diagnosed with Parkinson’s disease. In addition, globally around 7 to 10 million people are subjected to Parkinson’s disease. Even though the treatment of Parkinson’s disease via GDNF is still under trials, it has shown to be effective in the small clinical trials that have been conducted so far. The major limitation witnessed during the treatment is the administration of GDNF in the form of tablet or injection. Continuous developments and investments in the research studies are expected to drive the growth of global glial cell line derived neurotrophic factor (GDNF) market.

The report provides detailed qualitative and quantitative analysis of the global glial cell line derived neurotrophic factor market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type, and application in each of the major regions of the world.

Global Glial Cell Line Derived Neurotrophic Factor Market Player Analysis -

The report presents detailed analysis of major players operating in global glial cell line derived neurotrophic factor market. Few of them include Treeway BV, UniQure NV, and GlaxoSmithKline Plc. Detailed coverage on these market players with information on their revenue from glial cell line derived neurotrophic factor business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global glial cell line derived neurotrophic factor market is segmented on the basis of type, application, and geography. On the basis of type, the market is categorized into TW-002, AMT-090, GSK-812, LAUR-301, and others. By application, the market is segmented into brain ischemia, retinal degeneration, Parkinson’s disease, amyotrophic lateral sclerosis, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Glial Cell Line Derived Neurotrophic Factor Market Segmentation

By Type
   • TW-002
   • AMT-090
   • GSK-812
   • LAUR-301
   • Others

By Application
   • Brain Ischemia
   • Retinal Degeneration
   • Parkinson's Disease
   • Amyotrophic Lateral Sclerosis
   • Others

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Glial Cell Line Derived Neurotrophic Factor Market Key Players

• Treeway BV
• UniQure NV
• GlaxoSmithKline Plc

Please fill in the form below to Request for Customized Report
  
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

  
Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Glial Cell Line Derived Neurotrophic Factor Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Glial Cell Line Derived Neurotrophic Factor Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options





Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities

Customize

  • We offer 20% free customization on every purchase.

Get in touch!

  +91-844-601-6060


  help@esticastresearch.com